Dr Brendan Shaw is the principal of Shawview Consulting, the former CEO of Medicines Australia and assistant director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a special comment, Dr Shaw discusses the recent focus on domestic manufacturing capability.
New industrial policy for biopharmaceutical and devices industry needs careful thought
April 17, 2020 Latest NewsNews of the Day![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/31fd385bbba85fbc150ca538e26373ba.png)
Latest Video
New Stories
-
Omico calls for major government-industry support of fundamental change in cancer treatment
February 5, 2025 - - Latest News -
The mindset is that equitable access can only be achieved by denying everyone on the same basis
February 5, 2025 - - Latest News -
Baxter Kidney Care is now Vantive, a standalone organ therapy company
February 5, 2025 - - Latest News -
How is it fair that patients have no rights in this system of health technology assessment?
February 4, 2025 - - Latest News -
Pharmac tables proposal to fund a new oral contraceptive
February 4, 2025 - - Latest News -
'For many people living with cancer, the journey is complex and fraught with difficulties'
February 4, 2025 - - Latest News -
Patients have, in the health minister's own words, died waiting for this process
February 3, 2025 - - Latest News